Issue link: https://nebusinessmedia.uberflip.com/i/1544464
16 Worcester Business Journal | April 20, 2026 | wbjournal.com Largest life sciences & biotech companies Ranked by number of local employees Company Local employees/ worldwide employees/ annual revenue Focus or products Chief executive(s)/ year founded 1 Boston Scientific Corp. 300 Boston Scientific Way, Marlborough 01752 508-683-5670 • bostonscientific.com 2,800 (1) 55,000 $20 billion Global developer, manufacturer and marketer of medical devices that are used in interventional medical specialties Michael F. Mahoney chairman & CEO 1979 2 Bristol Myers Squibb 38 Jackson Road, Devens 01434 978-588-6001 • bms.com 1,680 (2) 32,500 $48 billion Discovery, development & delivery of medicines to prevail over serious disease Christopher S. Boerner chairman & CEO Odile Smith vice president & site lead, Devens 1887 3 Sanofi 68 New York Ave., Framingham 01701 508-271-3900 • sanofi.com 1,329 83,000 $53 billion Pharmaceuticals Manuela Buxo head, specialty care 1981 4 Insulet Corp. 100 Nagog Park, Acton 01720 978-600-7000 • insulet.com 1,249 5,411 $3 billion Medical devices targeting diabetes Ashley McEvoy president & CEO 2000 5 Quest Diagnostics 200 Forest St., Marlborough 01752 866-697-8378 • questdiagnostics.com 1,100 57,000 $11 billion Diagnostic information services Jim Davis chairman, CEO & president 1967 6 Integrated Genetics (Labcorp) 3400 Computer Drive, Westborough 01581 508-898-9001 • integratedgenetics.com 1,000 (3) 61,770 (4) $14 billion (4) Healthcare diagnostics Adam Schechter president & CEO, Labcorp 1991 7 Waters Corp. (5) 34 Maple St., Milford 01757 508-482-2000 • waters.com 789 16,000 $3 billion Analytical instruments, separations technologies and software for life, materials, food and environmental sciences Udit Batra president & CEO 1958 8 Cytiva, a Danaher co. (6) 100 Results Way, Marlborough 01752 508-475-2000 • cytiva.com 715 (7) N/A N/A Life sciences and biotherapeutics Chris Riley CEO, Cytiva Emmanuel Abate president, genomic medicine (8) 1733 9 KARL STORZ Endovision Inc. 91 Carpenter Hill Road, Charlton 01507 508-248-9011 • karlstorz.com 600 (2) 600 (2) N/A Endoscopes, medical instruments and medical technology Richard Santora executive director, production operations 1989 10 Tegra Medical 16 Forge Parkway, Franklin 02038 508-541-4200 • tegramedical.com 500 (2) 1,300 (2) N/A End-to-end contract manufacturing of complex components and finished medical devices Walter Kobler CEO 2007 11 Olympus Corp. of the Americas 800 West Park Drive, Westborough 01581 508-804-2600 • olympusamerica.com 453 29,297 $7 billion Endoscopes, laparoscopes, video imaging systems, surgical energy devices, system integration solutions, medical services and endotherapy instruments and devices Richard Reynolds regional president, Olympus Corp. in the Americas Mike Noyes president, Olympus Surgical Technologies America (9) 1968 12 Hologic Inc. (10) 250 Campus Drive, Marlborough 01752 508-263-2900 • hologic.com 413 7,300 $4 billion (11) Global medical technology company primarily focused on women's health Joe Almeida CEO 1985 13 SMC Ltd. 18 Independence Drive, Devens 01434 978-422-6800 • smcltd.com 400 2,250 N/A Worldwide contract manufacturing for medical, diagnostic and drug delivery devices Brian Payson vice president & general manager 1988 14 AbbVie Inc. 100 Research Drive, Worcester 01605 508-849-2500 • abbvie.com 350 57,000 $61 billion Biopharmaceuticals Robert A. Michael CEO 2013 15 Astellas Institute for Regenerative Medicine 9 Technology Drive, Westborough 01581 508-599-6700 • astellas.com 280 13,500 N/A Regenerative medicine and cell therapy research in ophthalmology and other therapeutic areas Erin Kimbrel head, cell & gene therapy research 2016 16 Rentschler Biopharma Inc. 27 Maple St., Milford 01757 508-282-5800 • rentschler-biopharma.com/en-us/ 270 1,400 N/A Customized full-service solutions for bioprocess development and production of complex biopharmaceuticals Uwe Buecheler interim CEO Tom Roberts president & general manager, U.S. 1927 17 Veranova 25 Patton Road, Devens 01434 978-784-5000 • veranova.com 250 (2) 800 (2) N/A Contract development and manufacturing of specialist and complex APIs for pharma and biotech customers Mike Riley CEO 1970 18 Cogmedix, a Coghlin Co. 127 Hartwell St., West Boylston 01583 800-640-3760 • cogmedix.com 200 900 N/A Medical device product development and manufacturing Chris Coghlin president & CEO 2008 18 UMass Chan Medical School Research Core Facilities 55 Lake Avenue North, Worcester 01655 508-856-4522 • umassmed.edu/research/cores 200 200 $28 million More than 40 research cores offering multiple services (12) Cynthia Nicholson interim chief of staff 1962 Source: Each company via survey as of Q1-Q2 2026. Notes: Waltham's Thermo Fisher Scientific Corp. announced the closure of its Franklin facility in Q1 2026; it last reported 380 workers at the site in 2024. Florida-based Jabil confirmed closure of its Clinton facility in Q1 2026; it employed 1,000 people at the site as of 2023, but had not disclosed the local employee count since then. Unable to confirm data by press time for Marlborough's Lifeline. N/A=not available. (1) Includes customer fulfillment center in Quincy (2) Data from WBJ's 2025 survey (3) Local employee count falls within a range of 1,000 to 4,999, according to Mass. Executive Office of Labor and Workforce Development; last responded to WBJ's 2021 survey with 436 local employees. (4) Revenue and companywide employee count is for Labcorp. (5) In February 2026, completed acquisition of the biosciences and diagnostic solutions businesses of New Jersey-based Becton, Dickinson and Co., in a transaction valued at $18.8 billion. (6) Part of Global Life Sciences Solutions U.S. LLC (7) Estimate based on 800 employees reported on WBJ's 2025 survey and a March 2025 announcement to lay off 85 in Westborough (8) Formerly GE Healthcare (9) Also, senior vice president, surgical and interventional solutions ISD operations (10) In April 2026, Hologic was acquired for $18.3 billion by multinational alternative asset managers Blackstone of New York City and TPG of San Francisco; headquarters remain in Marlborough, and the company is no longer publicly traded. (11) For fiscal year ended Sept. 27, 2025 (12) 3D printing, flow cytometry, imaging, CryoEM, vector production, drug design, mass spectrometry, fly food, MRI, tissue samples, transgenic animals and more -Compiled by: Stephanie R. Meagher, research@nebusinessmedia.com F O C U S HEALTH CARE